MedPath
NMPA Approval

Loteprednol Etabonate Ophthalmic Suspension

国药准字HJ20180059

May 11, 2023

H20180059

Drug Information

氯替泼诺混悬滴眼液

眼用制剂

0.2%(5ml:10mg;10ml:20mg)

化学药品

May 11, 2023

March 28, 2028

Company Information

Applicant Company

400 Somerset Corporate Blvd, Bridgewater, NJ 08807 USA

Manufacturing Company

8500 Hidden River Parkway, Tampa, Florida 33637

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氯替泼诺混悬滴眼液 - NMPA 批准文号 | MedPath